Related Experiment Video
Updated: Aug 8, 2026
Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology
Published on: November 7, 2010
N-(4-hydroxyphenyl) retinamide inhibits cystogenesis by polycystic epithelial cell lines in vitro
Abstract:
Primary tubular epithelial cells develop spherical monolayered cysts when cultured in collagenI matrix, a model that has been used to study the mechanism of cystogenesis. In an attempt to block cystogenesis, we have evaluated the effect of N-(4-hydroxyphenyl) retinamide (HPR), a synthetic derivative of retinoic acid, on both formation and growth of cysts in a human model of polycystic kidney cells. Number, dimension and submicroscopical characteristics of cysts were evaluated after 2 and 4 weeks from treatment with HPR. A marked inhibitory effect of HPR on cystogenesis was found at concentration of 1 microM, while a complete block was observed at concentration between 5 and 10 microM. Furthermore, treatment with HPR of already formed cysts resulted in their disruption. HPR at 10 microM also induced apoptosis of several tubular epithelial cell models suggesting a correlation between the two phenomena. Taken together these observations demonstrate that HPR blocks cystogenesis by polycystic kidney cells "in vitro" and that it also reverts the fate of already formed cysts. Apoptosis may be the mechanism which mediates the inhibitory effect on cystogenesis in this model.
Insights
N-(4-hydroxyphenyl) retinamide (HPR) effectively blocks polycystic kidney cell cystogenesis in vitro. This synthetic retinoid derivative also disrupts existing cysts and may induce apoptosis, offering a potential therapeutic strategy.
Area of Science:
- Cell Biology
- Renal Physiology
- Pharmacology
Background:
- Polycystic kidney disease (PKD) is characterized by cyst formation in kidney tubules.
- Cystogenesis models using primary tubular epithelial cells in collagen I matrix are crucial for studying PKD mechanisms.
- Understanding factors that inhibit cyst formation and growth is essential for developing therapeutic interventions.
Purpose of the Study:
- To evaluate the efficacy of N-(4-hydroxyphenyl) retinamide (HPR), a synthetic retinoid derivative, in blocking cystogenesis in a human polycystic kidney cell model.
- To assess the impact of HPR on both the formation and growth of kidney cysts.
- To investigate the potential mechanism of HPR's action, including its effect on apoptosis.
Main Methods:
- Primary tubular epithelial cells from human polycystic kidney cells were cultured in a collagen I matrix.
- Cells were treated with varying concentrations of HPR (1-10 microM) for 2 and 4 weeks.
- Cyst number, dimensions, and submicroscopic characteristics were analyzed.
- The effect of HPR on pre-formed cysts and induction of apoptosis in tubular epithelial cells was assessed.
Main Results:
- HPR demonstrated a marked inhibitory effect on cystogenesis at 1 microM.
- Complete blockage of cyst formation was observed at HPR concentrations between 5 and 10 microM.
- Treatment with HPR disrupted already formed cysts.
- HPR at 10 microM induced apoptosis in tubular epithelial cell models, suggesting a correlation.
Conclusions:
- HPR effectively inhibits cystogenesis in human polycystic kidney cells in vitro.
- HPR can disrupt established kidney cysts, indicating a potential for reversing disease progression.
- Apoptosis is suggested as the primary mechanism underlying HPR's inhibitory effect on cystogenesis.
